Phospholipase A as a potent virulence factor of Vibrio vulnificus

International Journal of Molecular Medicine

Volumn 20, Issue 6, 2007, Pages 913-918

  Koo, Bon Sun ^a   Lee, Ji Hyun ^a   Kim, Soon Cheol ^a   Yoon, Ha Yong ^a   Kim, Kyung Ah ^a   Kwon, Kang Beom ^b   Kim, Hyung Rho ^a   Park, Jin Woo ^a   Park, Byung Hyun ^a  

^a Chonbuk National University   (South Korea)

^b Wonkwang University   (South Korea)

Author keywords

Calcium; Hemolysis; Phospholipase A; Tetracycline; V. vulnificus

Indexed keywords

PHOSPHOLIPASE A; VIRULENCE FACTOR;

ANIMAL; ARTICLE; CYTOLOGY; ENZYMOLOGY; GRAM NEGATIVE INFECTION; HUMAN; MACROPHAGE; METABOLISM; MICROBIOLOGY; MOUSE; PATHOGENICITY; VIBRIO VULNIFICUS;

ANIMALS; HUMANS; MACROPHAGES; MICE; PHOSPHOLIPASES A; VIBRIO INFECTIONS; VIBRIO VULNIFICUS; VIRULENCE FACTORS;

EID: 42149108130     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.20.6.913     Document Type: Article

References (36)

1. Blake PA, Merson MH, Weaver RE, Hollis DG and Heublein PC: Disease caused by a marine Vibrio. Clinical characteristics and epidemiology. N Engl J Med 300: 1-5, 1979.
2. Hlady WG and Klontz KC: The epidemiology of Vibrio infections in Florida, 1981-1993. J Infect Dis 173: 1176-1183, 1996.
3. Park JW, Ma SN, Song ES, Song CH, Chae MR, Park BH, Rho RW, Park SD and Kim HR: Pulmonary damage by Vibrio vulnificus cytolysin. Infect Immun 64: 2873-2876, 1996.
4. Kreger AS, Kothary MH and Gray LD: Cytolytic toxins of Vibrio vulnificus and Vibrio damsela. Methods Enzymol 165: 176-189, 1988.
5. Wright AC, Simpson LM and Oliver JD: Role of iron in the pathogenesis of Vibrio vulnificus infections. Infect Immun 34: 503-507, 1981.
6. Miyoshi S and Shinoda S: Role of the protease in the permeability enhancement by Vibrio vulnificus. Microbiol Immunol 32: 1025-1032, 1988.
7. Testa J, Daniel LW and Kreger AS: Extracellular phospholipase A2 and lysophospholipase produced by Vibrio vulnificus. Infect Immun 45: 458-463, 1984. (Pubitemid 14092624)
8. Wright AC, Powell JL, Kaper JB and Morris JG Jr: Identification of a group 1-like capsular polysaccharide operon for Vibrio vulnificus. Infect Immun 69: 6893-6901, 2001.
9. Nishijima M, Nakaike S, Tamori Y and Nojima S: Detergent-resistant phospholipase A of Escherichia coli K-12. Purification and properties. Eur J Biochem 73: 115-124, 1977. (Pubitemid 8044269)
10. Park SD, Shon HS and Joh NJ: Vibrio vulnificus septicemia in Korea: clinical and epidemiologic findings in seventy patients. J Am Acad Dermatol 24: 397-403, 1991.
11. Hor LI, Chang TT and Wang ST: Survival of Vibrio vulnificus in whole blood from patients with chronic liver diseases: association with phagocytosis by neutrophils and serum ferritin levels. J Infect Dis 179: 275-278, 1999.
12. Bullen JJ, Spalding PB, Ward CG and Gutteridge JM: Hemochromatosis, iron and septicemia caused by Vibrio vulnificus. Arch Intern Med 151: 1606-1609, 1991.
13. Helms SD, Oliver JD and Travis JC: Role of heme compounds and haptoglobin in Vibrio vulnificus pathogenicity. Infect Immun 45: 345-349, 1984.
14. Nishina Y, Miyoshi S, Nagase A and Shinoda S: Significant role of an exocellular protease in utilization of heme by Vibrio vulnificus. Infect Immun 60: 2128-2132, 1992.
15. Snijder HJ and Dijkstra BW: Bacterial phospholipase A: structure and function of an integral membrane phospholipase. Biochim Biophys Acta 1488: 91-101, 2000.
16. Kim HR, Rho HW, Jeong MH, Park JW, Kim JS, Park BH, Kim UH and Park SD: Hemolytic mechanism of cytolysin produced from V. vulnificus. Life Sci 53: 571-577, 1993. (Pubitemid 23205584)
17. Oliver JD, Wear JE, Thomas MB, Warner M and Linder K: Production of extracellular enzymes and cytotoxicity by Vibrio vulnificus. Diagn Microbiol Infect Dis 5: 99-111, 1986.
18. Stelma GN Jr, Reyes AL, Peeler JT, Johnson CH and Spaulding PL: Virulence characteristics of clinical and environmental isolates of Vibrio vulnificus. Appl Environ Microbiol 58: 2776-2782, 1992.
19. Kwon KB, Yang JY, Ryu DG, Rho HW, Kim JS, Park JW, Kim HR and Park BH: Vibrio vulnificus cytolysin induces superoxide anion-initiated apoptotic signaling pathway in human ECV304 cells. J Biol Chem 276: 47518-47523, 2001.
20. Wright AC and Morris JG Jr: The extracellular cytolysin of Vibrio vulnificus: inactivation and relationship to virulence in mice. Infect Immun 59: 192-197, 1991.
21. Anderson BO, Brown JM, Shanley PF, Bensard DD and Harken AH: Marginating neutrophils are reversibly adherent to normal lung endothelium. Surgery 109: 51-61, 1991.
22. Bernheimer AW and Schwartz LL: Isolation and composition of staphylococcal alpha-toxin. J Gen Microbiol 30: 455-468, 1963.
23. 2 to measure bacterial enzyme levels. Clin Chim Acta 189: 39-46, 1990.
24. Mishell BB and Shiigi SM. Preparation of mouse cell suspensions. In: Selected Methods in Cellular Immunology. Mishell BB and Shiigi SM (eds). W.H. Freeman and Company, San Francisco, pp3-27, 1980.
25. Detrick-Hooks B, Borsos T and Rapp HJ: Quantitative comparison of techniques used to measure complement-mediated cytotoxicity of nucleated cells. J Immunol 114: 287-290, 1975.
26. 2. J Rheumatol 25: 1807-1812, 1998.
27. 2 activity and platelet aggregation by mepacrine (quinacrine). Biochim Biophys Acta 713: 170-172, 1982.
28. Lanni C and Becker EL: Inhibition of neutrophil phospholipase A2 by p-bromophenylacyl bromide, nordihydroguaiaretic acid, 5,8,11,14-eicosatetraynoic acid and quercetin. Int Arch Allergy Appl Immunol 76: 214-217, 1985.
29. Hostetler KY and Hall LB: Inhibition of kidney lysosomal phospholipases A and C by aminoglycoside antibiotics: possible mechanism of aminoglycoside toxicity. Proc Natl Acad Sci USA 79: 1663-1667, 1982.
30. Hor LI, Chang YK, Chang CC, Lei HY and Ou JT: Mechanism of high susceptibility of iron-overloaded mouse to Vibrio vulnificus infection. Microbiol Immunol 44: 871-878, 2000.
31. Shinoda S, Miyoshi S, Yamanaka H and Miyoshi-Nakahara N: Some properties of Vibrio vulnificus hemolysin. Microbiol Immunol 29: 583-590, 1985.
32. Ghannoum MA: Potential role of phospholipases in virulence and fungal pathogenesis. Clin Microbiol Rev 13: 122-143, 2000.
33. Songer JG: Bacterial phospholipases and their role in virulence. Trends Microbiol 5: 156-161, 1997.
34. Schmiel DH and Miller VL: Bacterial phospholipases and pathogenesis. Microbes Infect 1: 1103-1112, 1999.
35. Dekker N: Outer-membrane phospholipase A: known structure, unknown biological function. Mol Microbiol 35: 711-717, 2000.
36. Ubarretxena-Belandia I, Boots JW, Verheij HM and Dekker N: Role of the cofactor calcium in the activation of outer membrane phospholipase A. Biochemistry 37: 16011-16018, 1998.